Chlamydia screening or prophylaxis before laparoscopy and dye hydrotubation: no readmissions, no worry, or is that so?
We present a retrospective analysis of 120 laparoscopy and dye hydrotubation procedures. Our aim was to assess chlamydia screening or prophylaxis before, and the rate of readmission after, such procedures. We found evidence of a chlamydia screening test performed in 109 cases. Of the 37 women where antibiotic cover should have been considered, only 18 were treated. There were no readmissions for suspected pelvic inflammatory disease or for other complications. Our study may not have demonstrated any acute clinical recurrences, but there is a potential for subclinical reactivation or for delayed clinical recurrence leading to tubal damage in the untreated women.
Siassakos
Dimitrios
D
Obstetrics and Gynaecology, Taunton and Somerset Hospital, Taunton, UK. jsiasakos@hotmail.com
Manley
Kristyn
K
Wardle
Peter
P
Halawa
Shehrazad
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D002689:Chlamydia / Q000302:isolation & purification; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000517:prevention & control*; D004396:Coloring Agents; D005184:Fallopian Tube Diseases; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000209:etiology; D010535:Laparoscopy / Q000009:adverse effects*; D008403:Mass Screening / Q000379:methods*; D000292:Pelvic Inflammatory Disease
D000900:Anti-Bacterial Agents; D004396:Coloring Agents